Glaxo HIV drug aims to beat side effects
Glaxo Wellcome, the UK pharmaceuticals company, presented clinical trial data for abacavir, an HIV drug submitted last week to US, Canadian and European authorities for approval. Glaxo, which was
Glaxo Wellcome, the UK pharmaceuticals company, presented clinical trial data for abacavir, an HIV drug submitted last week to US, Canadian and European authorities for approval. Glaxo, which was